Eisai Co. Ltd. (ESAIY)
PNK: ESAIY
· Real-Time Price · USD
7.12
-0.09 (-1.25%)
At close: May 01, 2025, 2:59 PM
-1.25% (1D)
| Bid | 7.12 |
| Market Cap | 8.05B |
| Revenue (ttm) | 733.85B |
| Net Income (ttm) | 32.65B |
| EPS (ttm) | 0.36 |
| PE Ratio (ttm) | 19.78 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 7.15 |
| Volume | 1,011 |
| Avg. Volume (20D) | 205,434 |
| Open | 7.17 |
| Previous Close | 7.21 |
| Day's Range | 7.12 - 7.17 |
| 52-Week Range | 5.94 - 11.68 |
| Beta | -0.16 |
About ESAIY
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the ...
Sector Healthcare
IPO Date Feb 2, 2023
Employees 11,067
Stock Exchange PNK
Ticker Symbol ESAIY
Website https://www.eisai.co.jp
